MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-26-2026
Celcuity Shares 2011-2026 | CELC
Annual Shares Celcuity
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 46.8 M | 39.4 M | 23.7 M | 15.4 M | 13.4 M | 10.3 M | 10.2 M | 10.1 M | 7.46 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 46.8 M | 7.46 M | 19.6 M |
Quarterly Shares Celcuity
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.6 M | 43.7 M | 43.1 M | 37.1 M | 42.8 M | 38.4 M | 33.6 M | 25.5 M | 22.1 M | 22 M | 21.7 M | 21.7 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 12.6 M | 11.1 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 6.85 M | 6.44 M | 6.44 M | - | 6.44 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 47.6 M | 6.44 M | 18.2 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Danaher Corporation
DHR
|
713 M | $ 190.0 | -1.1 % | $ 135 B |  USA |
 |
Agilent Technologies
A
|
304 M | $ 113.67 | -1.02 % | $ 34.6 B | USA |
 |
DexCom
DXCM
|
390 M | $ 63.2 | -0.02 % | $ 24.7 B | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 16.15 | -1.64 % | $ 488 M | USA |
 |
Guardant Health
GH
|
125 M | $ 90.12 | 0.51 % | $ 11.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 108.1 | -1.39 % | $ 8.92 B |  Irlanda |
 |
Illumina
ILMN
|
159 M | $ 126.13 | -1.26 % | $ 20.1 B | USA |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 17.45 | -2.1 % | $ 930 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 271.38 | -1.12 % | $ 22.6 B | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 76.57 | 0.89 % | $ 5.17 B | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 501.25 | 1.06 % | $ 14.5 B | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 16.3 | -0.03 % | $ 176 M |  China |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 4.64 | -0.54 % | $ 430 M | USA |
 |
NeoGenomics
NEO
|
128 M | $ 7.94 | -1.06 % | $ 1.02 B | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 9.95 | 4.08 % | $ 2.16 B | USA |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 17.06 | -1.56 % | $ 382 M | USA |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Natera
NTRA
|
98.4 M | $ 206.55 | 0.82 % | $ 20.3 B | USA |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Pacific Biosciences of California
PACB
|
300 M | $ 1.43 | 0.35 % | $ 429 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
904 M | $ 26.79 | -1.51 % | $ 20 B |  Niderland |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Precipio
PRPO
|
1.61 M | $ 26.03 | 0.19 % | $ 41.8 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
Personalis
PSNL
|
59.3 M | $ 6.12 | -6.99 % | $ 363 M | USA |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 167.94 | -0.17 % | $ 8.32 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Sotera Health Company
SHC
|
284 M | $ 14.7 | -1.18 % | $ 4.17 B | USA |
 |
Soleno Therapeutics
SLNO
|
50.8 M | $ 52.27 | 0.03 % | $ 2.66 B | USA |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 24.81 | 0.32 % | $ 689 M | USA |
 |
Neuronetics
STIM
|
66 M | $ 1.56 | -11.65 % | $ 103 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
|
Biodesix
BDSX
|
130 M | $ 14.68 | -4.46 % | $ 1.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
377 M | $ 484.64 | -0.73 % | $ 183 B | USA |
 |
Trinity Biotech plc
TRIB
|
83.6 M | $ 0.59 | -4.96 % | $ 61.9 M | Irlanda |
 |
VolitionRx Limited
VNRX
|
126 M | $ 0.17 | -1.54 % | $ 21.4 M |  Singapore |
 |
Waters Corporation
WAT
|
59.5 M | $ 303.0 | -0.36 % | $ 18 B | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
32.5 K | $ 2.63 | 1.54 % | $ 85.4 K | USA |
 |
Biomerica
BMRA
|
2.3 M | $ 2.13 | -1.84 % | $ 4.89 M | USA |
 |
BioNano Genomics
BNGO
|
5.44 M | $ 1.15 | - | $ 6.26 M | USA |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 1.99 | 1.02 % | $ 8.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M |  Israel |